Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 3
2005 2
2006 3
2007 10
2008 7
2009 13
2010 10
2011 10
2012 8
2013 18
2014 14
2015 23
2016 35
2017 29
2018 28
2019 17
2020 13
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

227 results
Results by year
Filters applied: . Clear all
Page 1
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.
Zhang Z, Lee JC, Lin L, Olivas V, Au V, LaFramboise T, Abdel-Rahman M, Wang X, Levine AD, Rho JK, Choi YJ, Choi CM, Kim SW, Jang SJ, Park YS, Kim WS, Lee DH, Lee JS, Miller VA, Arcila M, Ladanyi M, Moonsamy P, Sawyers C, Boggon TJ, Ma PC, Costa C, Taron M, Rosell R, Halmos B, Bivona TG. Zhang Z, et al. Among authors: choi yj. Nat Genet. 2012 Jul 1;44(8):852-60. doi: 10.1038/ng.2330. Nat Genet. 2012. PMID: 22751098 Free PMC article.
Epigenetic priming by Dot1l in lymphatic endothelial progenitors ensures normal lymphatic development and function.
Yoo H, Lee YJ, Park C, Son D, Choi DY, Park JH, Choi HJ, La HW, Choi YJ, Moon EH, Saur D, Chung HM, Song H, Do JT, Jang H, Lee DR, Park C, Lee OH, Cho SG, Hong SH, Kong G, Kim JH, Choi Y, Hong K. Yoo H, et al. Among authors: choi yj. Cell Death Dis. 2020 Jan 6;11(1):14. doi: 10.1038/s41419-019-2201-1. Cell Death Dis. 2020. PMID: 31908356 Free PMC article.
227 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page